These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18423590)

  • 21. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus.
    Lowry CA; Hale MW; Evans AK; Heerkens J; Staub DR; Gasser PJ; Shekhar A
    Ann N Y Acad Sci; 2008 Dec; 1148():86-94. PubMed ID: 19120094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease.
    Pang TY; Du X; Zajac MS; Howard ML; Hannan AJ
    Hum Mol Genet; 2009 Feb; 18(4):753-66. PubMed ID: 19008301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptides: relevance in treatment of depression and anxiety disorders.
    Madaan V; Wilson DR
    Drug News Perspect; 2009; 22(6):319-24. PubMed ID: 19771321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning.
    Sherrin T; Blank T; Saravana R; Rayner M; Spiess J; Todorovic C
    Neuroscience; 2009 Aug; 162(1):14-22. PubMed ID: 19362130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [What clinicians expect from animal models of depression].
    Nomura S; Shigemura J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):37-9. PubMed ID: 19562939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of repeated stressor exposure on the release of corticotropin-releasing hormone, arginine-vasopressin and bombesin-like peptides at the anterior pituitary.
    Merali Z; Hayley S; Kent P; McIntosh J; Bédard T; Anisman H
    Behav Brain Res; 2009 Mar; 198(1):105-12. PubMed ID: 19014976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The developmental origins of anxiety.
    Gross C; Hen R
    Nat Rev Neurosci; 2004 Jul; 5(7):545-52. PubMed ID: 15208696
    [No Abstract]   [Full Text] [Related]  

  • 28. Depression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene-environment interaction.
    Brown GW; Harris TO
    J Affect Disord; 2008 Nov; 111(1):1-12. PubMed ID: 18534686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early life genetic, epigenetic and environmental factors shaping emotionality in rodents.
    Holmes A; le Guisquet AM; Vogel E; Millstein RA; Leman S; Belzung C
    Neurosci Biobehav Rev; 2005; 29(8):1335-46. PubMed ID: 16095695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review.
    Gardier AM; Guiard BP; Guilloux JP; Repérant C; Coudoré F; David DJ
    Fundam Clin Pharmacol; 2009 Feb; 23(1):23-42. PubMed ID: 19267769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenome-transcriptome correlation unravels anxiety and depression related pathways.
    Gormanns P; Mueller NS; Ditzen C; Wolf S; Holsboer F; Turck CW
    J Psychiatr Res; 2011 Jul; 45(7):973-9. PubMed ID: 21255794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is preattentive bias predictive of autonomic reactivity in response to a stressor?
    Jansson B; Najström M
    J Anxiety Disord; 2009 Apr; 23(3):374-80. PubMed ID: 19150593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of gene-environment interactions in depression: evidence that genes potentiate multiple sources of adversity.
    Wichers M; Schrijvers D; Geschwind N; Jacobs N; Myin-Germeys I; Thiery E; Derom C; Sabbe B; Peeters F; Delespaul P; van Os J
    Psychol Med; 2009 Jul; 39(7):1077-86. PubMed ID: 18834553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRH signaling. Molecular specificity for drug targeting in the CNS.
    Refojo D; Holsboer F
    Ann N Y Acad Sci; 2009 Oct; 1179():106-19. PubMed ID: 19906235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.
    Basso AM; Bratcher NA; Harris RR; Jarvis MF; Decker MW; Rueter LE
    Behav Brain Res; 2009 Mar; 198(1):83-90. PubMed ID: 18996151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ascent of mouse: advances in modelling human depression and anxiety.
    Cryan JF; Holmes A
    Nat Rev Drug Discov; 2005 Sep; 4(9):775-90. PubMed ID: 16138108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabis and psychiatric disorders: it is not only addiction.
    Leweke FM; Koethe D
    Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The biology of depression.
    Prakash HM; Sumant K
    J Indian Med Assoc; 2000 May; 98(5):228-31. PubMed ID: 11203058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.
    Brown RF; Valpiani EM; Tennant CC; Dunn SM; Sharrock M; Hodgkinson S; Pollard JD
    Psychol Psychother; 2009 Mar; 82(Pt 1):41-56. PubMed ID: 18727845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurochemical and behavioral alterations in an inflammatory model of depression: sex differences exposed.
    Pitychoutis PM; Nakamura K; Tsonis PA; Papadopoulou-Daifoti Z
    Neuroscience; 2009 Apr; 159(4):1216-32. PubMed ID: 19409213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.